Search research articles
Contact Us
Filters
Showing results (481-490 of 538) with videos related to
Page
of 54
Sort By:
British Journal of Cancer
|
July 1, 1984
The Edinburgh randomised trial of screening for breast cancer: description of method
M M Roberts, F E Alexander, T J Anderson, et al.
Neuromuscular Disorders : NMD
|
October 10, 2013
Polymorphism in the TOMM40 gene modifies the risk of developing sporadic inclusion body myositis and the age of onset of symptoms
F L Mastaglia, A Rojana-udomsart, I James, et al.
Journal of Alzheimer'S Disease : JAD
|
July 17, 2023
The APOE-TOMM40 Humanized Mouse Model: Characterization of Age, Sex, and PolyT Variant Effects on Gene Expression
William K Gottschalk, Scott Mahon, Dellila Hodgson, et al.
Journal of Medicinal Chemistry
|
July 1, 1991
Design, synthesis, and pharmacological evaluation of ultrashort- to long-acting opioid analgetics
P L Feldman, M K James, M F Brackeen, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 1, 1994
A pharmacodynamic model to investigate the structure-activity profile of a series of novel opioid analgesics
M W Lutz, P H Morgan, M K James, et al.
The Pharmacogenomics Journal
|
December 24, 2009
A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease
A D Roses, M W Lutz, H Amrine-Madsen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
August 7, 2012
A homopolymer polymorphism in the TOMM40 gene contributes to cognitive performance in aging
Kathleen M Hayden, Jill M McEvoy, Colton Linnertz, et al.
Current Opinion in Pharmacology
|
February 26, 2014
New applications of disease genetics and pharmacogenetics to drug development
Allen D Roses, Ann M Saunders, Michael W Lutz, et al.
Neurology. Clinical Practice
|
May 11, 2026
Evaluating the Duke Iterative Cognitive Examination Against the Montreal Cognitive Assessment: Validity and Clinical Utility
Christine Park, Thomas J Farrer, Jill Z Stuart, et al.
Neurology
|
January 22, 2017
<i>TOMM40</i>'523 variant and cognitive decline in older persons with <i>APOE</i> ε3/3 genotype
Lei Yu, Michael W Lutz, Robert S Wilson, et al.
Page
of 54
Search research articles
Search
Showing results (481-490 of 538) with videos related to
Sort By:
Page
of 54
British Journal of Cancer
|
July 1, 1984
The Edinburgh randomised trial of screening for breast cancer: description of method
M M Roberts, F E Alexander, T J Anderson, et al.
Neuromuscular Disorders : NMD
|
October 10, 2013
Polymorphism in the TOMM40 gene modifies the risk of developing sporadic inclusion body myositis and the age of onset of symptoms
F L Mastaglia, A Rojana-udomsart, I James, et al.
Journal of Alzheimer'S Disease : JAD
|
July 17, 2023
The APOE-TOMM40 Humanized Mouse Model: Characterization of Age, Sex, and PolyT Variant Effects on Gene Expression
William K Gottschalk, Scott Mahon, Dellila Hodgson, et al.
Journal of Medicinal Chemistry
|
July 1, 1991
Design, synthesis, and pharmacological evaluation of ultrashort- to long-acting opioid analgetics
P L Feldman, M K James, M F Brackeen, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 1, 1994
A pharmacodynamic model to investigate the structure-activity profile of a series of novel opioid analgesics
M W Lutz, P H Morgan, M K James, et al.
The Pharmacogenomics Journal
|
December 24, 2009
A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease
A D Roses, M W Lutz, H Amrine-Madsen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
August 7, 2012
A homopolymer polymorphism in the TOMM40 gene contributes to cognitive performance in aging
Kathleen M Hayden, Jill M McEvoy, Colton Linnertz, et al.
Current Opinion in Pharmacology
|
February 26, 2014
New applications of disease genetics and pharmacogenetics to drug development
Allen D Roses, Ann M Saunders, Michael W Lutz, et al.
Neurology. Clinical Practice
|
May 11, 2026
Evaluating the Duke Iterative Cognitive Examination Against the Montreal Cognitive Assessment: Validity and Clinical Utility
Christine Park, Thomas J Farrer, Jill Z Stuart, et al.
Neurology
|
January 22, 2017
<i>TOMM40</i>'523 variant and cognitive decline in older persons with <i>APOE</i> ε3/3 genotype
Lei Yu, Michael W Lutz, Robert S Wilson, et al.
Page
of 54